These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26649829)

  • 1. Topical Ruxolitinib for the Treatment of Alopecia Universalis.
    Craiglow BG; Tavares D; King BA
    JAMA Dermatol; 2016 Apr; 152(4):490-1. PubMed ID: 26649829
    [No Abstract]   [Full Text] [Related]  

  • 2. Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring.
    Vandiver A; Girardi N; Alhariri J; Garza LA
    Int J Dermatol; 2017 Aug; 56(8):833-835. PubMed ID: 28322434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruxolitinib-induced reversal of alopecia universalis in a patient with essential thrombocythemia.
    Pieri L; Guglielmelli P; Vannucchi AM
    Am J Hematol; 2015 Jan; 90(1):82-3. PubMed ID: 25307179
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata.
    Bayart CB; DeNiro KL; Brichta L; Craiglow BG; Sidbury R
    J Am Acad Dermatol; 2017 Jul; 77(1):167-170. PubMed ID: 28619556
    [No Abstract]   [Full Text] [Related]  

  • 5. Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis.
    Palandri F; Palumbo GA; Elli EM; Polverelli N; Benevolo G; Martino B; Abruzzese E; Tiribelli M; Tieghi A; Latagliata R; Cavazzini F; Bergamaschi M; Binotto G; Crugnola M; Isidori A; Caocci G; Heidel F; Pugliese N; Bosi C; Bartoletti D; Auteri G; Cattaneo D; Scaffidi L; Trawinska MM; Stella R; Ciantia F; Pane F; Cuneo A; Krampera M; Semenzato G; Lemoli RM; Iurlo A; Vianelli N; Cavo M; Breccia M; Bonifacio M
    Blood Cancer J; 2021 Jan; 11(1):4. PubMed ID: 33414394
    [No Abstract]   [Full Text] [Related]  

  • 6. Ruxolitinib-conjugated gold nanoparticles for topical administration: An alternative for treating alopecia?
    Boca S; Berce C; Jurj A; Petrushev B; Pop L; Gafencu GA; Selicean S; Moisoiu V; Temian D; Micu WT; Astilean S; Braicu C; Tomuleasa C; Berindan-Neagoe I
    Med Hypotheses; 2017 Nov; 109():42-45. PubMed ID: 29150291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata.
    Deeb M; Beach RA
    J Cutan Med Surg; 2017; 21(6):562-563. PubMed ID: 28635319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis.
    Caocci G; Maccioni A; Murgia F; Perra A; Usai M; Piga M; Mascia R; La Nasa G
    Leuk Lymphoma; 2016 May; 57(5):1215-8. PubMed ID: 26308187
    [No Abstract]   [Full Text] [Related]  

  • 9. Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis.
    Maccaferri M; Leonardi G; Marasca R; Colaci E; Paolini A; Soci F; Forghieri F; Potenza L; Narni F; Luppi M
    Leuk Lymphoma; 2014 Sep; 55(9):2207-8. PubMed ID: 24354678
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study.
    Bokhari L; Sinclair R
    Int J Dermatol; 2018 Dec; 57(12):1464-1470. PubMed ID: 30160787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia Universalis and Chronic Graft-vs-Host Disease Treated With Ruxolitinib.
    Borg MA; Shalabi RA; Childs R; Wells BC
    JAMA Dermatol; 2018 Nov; 154(11):1357-1358. PubMed ID: 30285060
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement of bone marrow fibrosis with ruxolitinib: will this finding change our perception of the drug?
    Breccia M; Molica M; Colafigli G; Alimena G
    Expert Rev Hematol; 2015 Aug; 8(4):387-9. PubMed ID: 25915176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of dermatomyositis with ruxolitinib.
    Fioranelli M; Roccia MG; Lotti T
    Dermatol Ther; 2016 Jul; 29(4):285. PubMed ID: 26448614
    [No Abstract]   [Full Text] [Related]  

  • 14. Klebsiella pneumoniae primary liver abscess associated with ruxolitinib.
    Kusano Y; Terui Y; Ueda K; Hatake K
    Ann Hematol; 2016 Sep; 95(9):1561-2. PubMed ID: 27259987
    [No Abstract]   [Full Text] [Related]  

  • 15. Restoration of response to ruxolitinib upon brief withdrawal in two patients with myelofibrosis.
    Gisslinger H; Schalling M; Gisslinger B; Skrabs C; Müllauer L; Kralovics R
    Am J Hematol; 2014 Mar; 89(3):344-6. PubMed ID: 24273107
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistent janus kinase-signaling in chronic lymphocytic leukemia patients on ibrutinib: Results of a phase I trial.
    Spaner DE; McCaw L; Wang G; Tsui H; Shi Y
    Cancer Med; 2019 Apr; 8(4):1540-1550. PubMed ID: 30843659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruxolitinib for refractory large granular lymphocyte leukemia.
    Moignet A; Pastoret C; Cartron G; Coppo P; Lamy T
    Am J Hematol; 2021 Oct; 96(10):E368-E370. PubMed ID: 34133042
    [No Abstract]   [Full Text] [Related]  

  • 18. Ruxolitinib: evolution or revolution in treatment of patients with polycythemia vera?
    Beauverd Y; McLornan DP; Radia DH; Harrison CN
    Future Oncol; 2016 Mar; 12(6):739-49. PubMed ID: 26846873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruxolitinib for the treatment of patients with polycythemia vera.
    Kiladjian JJ; Winton EF; Talpaz M; Verstovsek S
    Expert Rev Hematol; 2015 Aug; 8(4):391-401. PubMed ID: 25980454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial.
    Verstovsek S; Vannucchi AM; Griesshammer M; Masszi T; Durrant S; Passamonti F; Harrison CN; Pane F; Zachee P; Kirito K; Besses C; Hino M; Moiraghi B; Miller CB; Cazzola M; Rosti V; Blau I; Mesa R; Jones MM; Zhen H; Li J; Francillard N; Habr D; Kiladjian JJ
    Haematologica; 2016 Jul; 101(7):821-9. PubMed ID: 27102499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.